Addyi was first accepted because of the FDA in August 2015 to take care of hypoactive sexual desire condition (HSDD) in premenopausal Girls. Which is just yet another way of claiming it boosts sexual intercourse drive (also called libido) in women that have not attained menopause. It had been the initial these types of drug authorized for this use.